May 31, 2017 10:53 AM EDT
News Briefing

Nicox shares soar on Zervi­ate OK; Gem­phire CEO re­signs; Ar­ray, Ono team up on a $187M deal

Emma Yasinski

→ Nicox’s Zervi­ate re­ceived FDA ap­proval to­day and $COX stocks have soared in re­sponse to the an­nounce­ment. The com­pa­ny pre­vi­ous­ly ran in­to trou­ble when …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

ADC sci­en­tist who paved the way for Dai­ichi’s En­her­tu dies

As­traZeneca re­veals first clin­i­cal da­ta for bis­pe­cif­ic T cell en­gager from TeneoT­wo buy­out

Biose­cure bill is left out of end-of-year de­fense pack­age, deal­ing blow to chances

Beam shares re­sults from sev­en pa­tients who re­ceived gene-edit­ed sick­le cell ther­a­py

Dutch biotech nabs €85M to po­si­tion in­flam­ma­to­ry an­ti­body for a phar­ma buy­er

sponsored

The key to faster, more im­pact­ful re­search? Put pa­tients in the dri­ver’s seat

A service from the Financial Times